Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionMK-5172A is the combination of MK-5172 and MK-8742
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV) infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today